Nau Roland, Schmidt-Schweda Stephan, Frank Tobias, Gossner Johannes, Djukic Marija, Eiffert Helmut
Department of Neuropathology University Medical Center Göttingen, Georg-August-University Göttingen Göttingen Germany.
Department of Geriatrics Evangelisches Krankenhaus Göttingen-Weende Göttingen Germany.
Clin Case Rep. 2023 Jun 2;11(6):e7462. doi: 10.1002/ccr3.7462. eCollection 2023 Jun.
Leukopenia, including agranulocytosis, is a severe complication of treatment with all β-lactam antibiotics. Its incidence increases with age. endocarditis after implantation of an aortic valve bio-prosthesis in a 77-year-old woman was treated with ceftriaxone 2 g/day plus gentamicin 160 mg/day intravenously. On Day 25 of treatment, blood leukocytes had decreased to 1800/μl (neutrophils 370/μl). Antibiotic therapy was switched to penicillin G 20 million international units (IU)/day. Thereafter, blood leukocytes including neutrophils normalized suggesting that penicillin G was less bone marrow-toxic than ceftriaxone. High-dose ciprofloxacin, the alternative to penicillin G, was avoided because of the risk of cognitive and behavioral side effects. The present case suggests that with close laboratory monitoring a β-lactam with differing side chains should not be considered contraindicated after β-lactam antibiotic-induced neutropenia.
白细胞减少症,包括粒细胞缺乏症,是所有β-内酰胺类抗生素治疗的严重并发症。其发病率随年龄增长而增加。一名77岁女性在植入主动脉瓣生物假体后发生心内膜炎,接受头孢曲松2克/天加庆大霉素160毫克/天静脉治疗。治疗第25天,血液白细胞降至1800/μl(中性粒细胞370/μl)。抗生素治疗改为青霉素G 2000万国际单位(IU)/天。此后,包括中性粒细胞在内的血液白细胞恢复正常,提示青霉素G的骨髓毒性低于头孢曲松。由于存在认知和行为副作用风险,避免使用高剂量环丙沙星作为青霉素G的替代药物。本病例表明,在密切的实验室监测下,β-内酰胺类抗生素诱导的中性粒细胞减少症后,不应将具有不同侧链的β-内酰胺类药物视为禁忌。